{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:08:04Z","timestamp":1791576484750,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cca.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T13:36:18Z","timestamp":1426167378000},"page":"7-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":166,"special_numbering":"C","title":["Cervical cancer: Biomarkers for diagnosis and treatment"],"prefix":"10.1016","volume":"445","author":[{"given":"Subramanyam","family":"Dasari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Wudayagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokanatha","family":"Valluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2015.03.005_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.cca.2015.03.005_bb0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnci\/87.11.779","article-title":"Cancer causes revisited: human papillomavirus and cervical neoplasia","volume":"87","author":"Franco","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cca.2015.03.005_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrc1781","article-title":"Predicting the future burden of cancer","volume":"6","author":"Brayand","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cca.2015.03.005_bb0020","first-page":"1107","article-title":"The present scenario of cervical cancer control and HPV epidemiology in India: an outline","volume":"12","author":"Senapathy","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.cca.2015.03.005_bb0025","first-page":"129","article-title":"Cancer biomarkers \u2014 current perspectives","volume":"132","author":"Anant","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.cca.2015.03.005_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.cca.2015.03.005_bb0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mob.2003.164","article-title":"Clinical findings among young women with genital human papillomavirus infection","volume":"188","author":"Mao","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2015.03.005_bb0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0095-4543(21)00940-4","article-title":"Cervical cancer screening. Past success and future challenge","volume":"19","author":"Dewar","year":"1992","journal-title":"Prim Care"},{"key":"10.1016\/j.cca.2015.03.005_bb0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.vaccine.2008.11.041","article-title":"Prevalence of human papillomavirus types in cervical and oral cancers in central India","volume":"27","author":"Gheit","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cca.2015.03.005_bb0050","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1158\/1078-0432.CCR-04-2213","article-title":"Translational crossroads for biomarkers","volume":"11","author":"Bast","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cca.2015.03.005_bb0055","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1359-6446(05)03487-2","article-title":"Recent advances in biomarkers for cancer diagnosis and treatment","volume":"10","author":"Upender","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cca.2015.03.005_bb0060","first-page":"1","article-title":"Genomic analysis of cancer","volume":"17","author":"Wang","year":"2003","journal-title":"Princ Pract Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1196\/annals.1318.003","article-title":"Challenges for biomarkers in cancer detection","volume":"1022","author":"Wagner","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2015.03.005_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02913308","article-title":"Tumor markers: an overview","volume":"22","author":"Malati","year":"2007","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.cca.2015.03.005_bb0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cncr.21378","article-title":"Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples","volume":"105","author":"Wentzensen","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2015.03.005_bb0080","first-page":"118","article-title":"Immunohistochemistry in assessment of molecular pathogenesis of cervical carcinogenesis","volume":"26","author":"Syrjanen","year":"2005","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0085","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","article-title":"Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study","volume":"325","author":"Kjaer","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.cca.2015.03.005_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ajog.2006.02.047","article-title":"For the ASCUS LSIL Triage Study (ALTS) Group: predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)","volume":"195","author":"Walker","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cca.2015.03.005_bb0095","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/dji186","article-title":"Human papillomavirus type 16 infections and 2-year absolute risk of cervical pre-cancer in women with equivocal or mild cytologic abnormalities","volume":"97","author":"Castle","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.cca.2015.03.005_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2003.09.006","article-title":"Human papillomavirus DNA in sera of cervical cancer patients as tumor marker","volume":"202","author":"Widschwendter","year":"2003","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.cca.2015.03.005_bb0105","doi-asserted-by":"crossref","first-page":"e43393","DOI":"10.1371\/journal.pone.0043393","article-title":"Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients","volume":"7","author":"Campitelli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2015.03.005_bb0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.biopha.2013.12.008","article-title":"Effect of concurrent radiochemotherapy and chemotherapy on serum proteins for prospective predictors of patients with HPV induced cervical cancer","volume":"68","author":"Dasari","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cca.2015.03.005_bb0115","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I","article-title":"Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma","volume":"40","author":"Kato","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2015.03.005_bb0120","series-title":"Clinical Gynecologic Oncology","first-page":"53","author":"Di Saia","year":"2002"},{"key":"10.1016\/j.cca.2015.03.005_bb0125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0029-7844(02)02204-4","article-title":"Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging","volume":"100","author":"Ohara","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2015.03.005_bb0130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1034\/j.1600-0412.2002.810513.x","article-title":"Preoperative serum SCC, CA125 and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix","volume":"81","author":"Takeda","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.cca.2015.03.005_bb0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/gyno.2000.5732","article-title":"Can initial serum CYFRA 21\u20131, SCC antigen and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?","volume":"77","author":"Gaarenstroom","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0140","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/1097-0142(19941101)74:9<2497::AID-CNCR2820740917>3.0.CO;2-L","article-title":"Serum level of squamous cell carcinoma antigen and tumor size is useful to identify preoperatively patients at high risk of cervical cancer","volume":"74","author":"Chou","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2015.03.005_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/gyno.1994.1272","article-title":"Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix","volume":"55","author":"Bolli","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0150","first-page":"61","article-title":"Serum fragments of cytokeratin subunit 19 measured by CYFRA 21\u20131 immunoradiometric assay as a marker of lung cancer","volume":"53","author":"Pujol","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2015.03.005_bb0155","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/gyno.1994.1309","article-title":"Prognostic significance of serum fragments of cytokeratin 19 measured by CYFRA 21\u20131 in cervical cancer","volume":"55","author":"Bonfrer","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0160","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s004320050352","article-title":"Serum CYFRA 21\u20131 in cervical cancer patients treated with radiation therapy","volume":"126","author":"Suzuki","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0165","first-page":"1765","article-title":"CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA","volume":"25","author":"Molina","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cca.2015.03.005_bb0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1084\/jem.122.3.467","article-title":"Specific carcinoembriyonic antigens of human digestive system","volume":"122","author":"Gold","year":"1965","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2015.03.005_bb0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4612-5068-5_5","article-title":"Role of carcinoembriyonic antigen assay in the management of cancer","volume":"1","author":"Sugarbaker","year":"1985","journal-title":"Adv Immun Cancer Ther"},{"key":"10.1016\/j.cca.2015.03.005_bb0180","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJM197107152850302","article-title":"Demonstration of an antigen common to several varieties of neoplasia","volume":"285","author":"Lo Gerfo","year":"1971","journal-title":"N Eng J Med"},{"key":"10.1016\/j.cca.2015.03.005_bb0185","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/1097-0142(197706)39:6<2365::AID-CNCR2820390609>3.0.CO;2-I","article-title":"Carcino-enbryonic antigen in cancer of the female reproductive system","volume":"39","author":"Disaia","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2015.03.005_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/gyno.1995.1126","article-title":"Tumor antigens CA 19.9, CA 125 and CEA in carcinoma of the uterine cervix","volume":"57","author":"Borras","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0195","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.1994.1112","article-title":"Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer","volume":"53","author":"Battaglia","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.critrevonc.2012.09.003","article-title":"Tissue biomarkers as prognostic variables of cervical cancer","volume":"86","author":"Gadducci","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cca.2015.03.005_bb0205","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/gyno.1999.5690","article-title":"High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion","volume":"76","author":"Ryu","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2009.09.011","article-title":"Prevalence and clinical relevance of cyclooxygenase-1 and -2 expressions in stage IIB cervical adenocarcinoma","volume":"148","author":"Jung","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.cca.2015.03.005_bb0215","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000227497","article-title":"Prognostic value of CD44 splices variant expression in ovarian cancer","volume":"52","author":"Uhl-Steidl","year":"1995","journal-title":"Oncology"},{"key":"10.1016\/j.cca.2015.03.005_bb0220","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/bjc.1997.611","article-title":"High serum level of soluble CD44 variant isoform v5 are associated with favorable clinical outcome in ovarian cancer","volume":"76","author":"Zeimet","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cca.2015.03.005_bb0225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/gyno.1995.1071","article-title":"Cytokeratin subunit 19 measured by CYFRA 21\u20131 assay in follow-up of cervical cancer","volume":"56","author":"Kainz","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0230","first-page":"1","article-title":"Evaluation of soluble CD44 protein marker to distinguish the benign and squamous cell carcinoma cases in cervical cancer Patients","volume":"31","author":"Subramanyam","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0235","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<801::AID-IJC11>3.0.CO;2-C","article-title":"Matrix-metalloproteinases and their inhibitors in plasma and tissue of patients with renal cell carcinoma","volume":"85","author":"Lein","year":"2000","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.cca.2015.03.005_bb0240","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1007\/s12032-012-0283-z","article-title":"Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer","volume":"29","author":"Li","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/annonc\/mdn552","article-title":"Serum YKL-40 as a marker for cervical adenocarcinoma","volume":"20","author":"Mitsuhashi","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cca.2015.03.005_bb0250","first-page":"3576","article-title":"Serum soluble Fas level as a prognostic factor in patients with gynecological malignancies","volume":"6","author":"Konno","year":"2000","journal-title":"Clin Cancer Res"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115001370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115001370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T03:44:07Z","timestamp":1651463047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898115001370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":50,"alternative-id":["S0009898115001370"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2015.03.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cervical cancer: Biomarkers for diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}